Construction of the country’s first plasma fractionation plant began at Bangabandhu Hi-Tech City in Gazipur on Monday.
Oryx Biotech is setting up the plant in collaboration with Summit Technopolis and with technical support from China Biologic Products Holdings.The company has pledged to invest a total of $300 million to set up the plant, according to the officials involved in the project.
State Minister for ICT Zunaid Ahmed Palak was the chief guest at the foundation laying event of the plant at Bangabandhu Hi-tech City in Kaliakoir of Gazipur on the outskirt of the capital.
Senior Secretary NM Zeaul Alam, Bangladesh Hi-tech Park Authority Managing Director Hosne Ara Begum and Summit Technopolis Managing Director Abu Reza Khan, Oryx Biotech Managing Director David Bow and Chinese Commercial Counselor Liu Zhenhua were also present on the occasion.
State Minister Palak said Oryx will invest $300 million in the project and around 2,000 engineers and scientists will be employed in the projects.
“Besides, the plant will also help the country save foreign currencies equivalent to Tk 10 billion annually on plasma import,” he said.
Oryx Biotech Chairman Kazi Shakil said the plant will produce life-saving therapeutics that are produced only in the most advanced countries of the world.Summit Group Director Fadiah Khan said Summit is welcoming hi-tech investors in Bangladesh to help open up new opportunities for the tech-savvy youth.
“Bangladesh has shown its resilience in COVID management and we are here to support the nation to take the next step of economic growth,”
Biotechnology is a commonly used technology in developed countries to produce biotech products plasma which is used to treat many deadly diseases.